Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

Suppressing REM sleep with antidepressants may increase survival in patients with amyotrophic lateral sclerosis.

Symptomatic children may have pulmonary embolism and/or deep vein thrombosis at similar rates to adults, despite current literature.